mgm4858am集团

      mgm4858am集团 /科研细胞 /人源细胞系 / /Caki-2(人肾透明细胞癌细胞)

      Caki-2(人肾透明细胞癌细胞)

      CBP60449

      询 价
      CAKI2细胞全景
      产品描述
      产品数据库
      I. General information 
      Synonyms: Caki-2
      Background: According to the originator, Caki-2 was established from a primary clear cell carcinoma of the kidney. This is another line isolated from a primary renal carcinoma by J. Fogh as indicated in the description for ATCC HTB-46.
      Species: Homo sapiens, human
      Tissue: kidney
      Disease: clear cell carcinoma
      Gender: Caucasian,male, 69 years
      Morphology: epithelial
      Growth Mode: adherent
      DNA Profile: Amelogenin: X,Y
      CSF1PO: 10,12
      D13S317: 10
      D16S539: 9,13
      D5S818: 11
      D7S820: 12
      THO1: 6
      TPOX: 9,11
      vWA: 16,17
      Our Cell Line Authentication Service
      Culture Medium:

      McCoy's 5a+10%FBS

      Caki-2完全培养基,# CBP60449M
      We strongly suggest to purchase the complete medium from us.

      Cryopreservation medium: 90%FBS+10%DMSO
      Antigen Expression: Blood Type A; Rh-
      Tumor Formation: Yes, in nude mice; forms clear cell carcinoma
      Comments: Recent evaluation (K. Pulkkanen and J. Parkinen, personal communication) of nude mouse tumors formed by this line in orthotopic and s.c. implantations were consistent with cystic papillary renal cell carcinoma according to the criteria of Kovacs et al.
      Ultrastructural features reported include microvilli and microfilaments with few mitochondria, lysosomes or lipid droplets. Frequent multilamellar bodies were observed, but no virus particles were seen.
      For more information, please contact us (4008-750-250).

      客服

      微信

      扫一扫,添加二维码

      电话

      留言

      药靶模型联系方式: 华东销售经理(上海):18240630236/18114809104 华东销售经理(江苏、安徽):15715191010 华北销售经理:18628311252 华南销售经理:13823536064 华中&华西销售经理:18071545918 全国销售经理:13816461235
      诊断标准品联系方式: 华东销售经理:15000320447 华北销售经理:18628311252 华南销售经理:13823536064 华中&华西销售经理:18071545918 全国销售经理:13816461235

      扫二维码

      立即提交